STAT3–STAT3 dimerization (signaling) is upregulated in difficult-to-treat cancers such as the triple negative breast cancer (TNBC) [148] and HCC, as well as lung, breast, renal, ovarian cancers and lymphomas [151,152,153,154,155,156]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.